Apply to trial NCT06720545

A few quick questions so the study team can decide if you might be a fit.

RecruitingDevice study

Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

Hypoglossal nerve stimulation (HGNS) is an implantable therapy that treats obstructive sleep apnea. The study will evaluate the effect of this treatment on cardiovascular and metabolism-related measures to see if it affects patients' risk of medical problems associated with obstructive sleep apnea (OSA).

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening